Corner Therapeutics Announces First Publication on Proprietary Catalytic Adjuvant Platform
WATERTOWN, Mass.--(BUSINESS WIRE)--Nov 8, 2023--<a ...
WATERTOWN, Mass.--(BUSINESS WIRE)--Nov 8, 2023--<a ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Nov 8, 2023--Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression, and other central nervous system (CNS) disorders, today announced that ...
ANN ARBOR, Mich.--(BUSINESS WIRE)--Nov 8, 2023--<a ...
SAN FRANCISCO--(BUSINESS WIRE)--Nov 8, 2023--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced it ranked first for the second year in a row on the 2023 Deloitte Technology Fast 500 鈩�, a list of the fastest-growing technology, media, telecommunications, life sciences, fintech and energy ...
SEATTLE & EXTON, Pa.--(BUSINESS WIRE)--Nov 8, 2023--<a ...
BOULDER, Colo.--(BUSINESS WIRE)--Nov 8, 2023--Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, announced today that members of its senior management team will participate in the following upcoming investor conferences:<em>Stifel 2023 ...